Impact on clinical outcomes of renin-angiotensin system inhibitors against doxorubicin-related toxicity in patients with breast cancer and hypertension: A nationwide cohort study in South Korea

BACKGROUND: Although doxorubicin (DOX) is a commonly used potent chemotherapeutic agent in patients with breast cancer, its cardiotoxic effect is a concern, particularly in patients with hypertension. Antihypertensive renin-angiotensin system (RAS) inhibitors may potentially play a role in preventin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Hui-Jeong, Lee, Taek-Gu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659172/
https://www.ncbi.nlm.nih.gov/pubmed/37983233
http://dx.doi.org/10.1371/journal.pone.0294649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659172/
https://www.ncbi.nlm.nih.gov/pubmed/37983233
http://dx.doi.org/10.1371/journal.pone.0294649

Ejemplares similares